Fabio Angeli,Gianpaolo Reboldi,Giovanni Mazzotta et al.
Fabio Angeli et al.
The goal of antihypertensive therapy is to reduce the risk associated with blood pressure elevation. Although the choice of first-line drug therapy may exert some effects on different long-term cardiovascular endpoints, randomized clinical ...
Afsaneh Talaei,Masoud Amini,Abdolatif Moini
Afsaneh Talaei
Background: Cardiovascular disease (CVD) is the most important cause of mortality in developed and developing countries. Hypertension is a major risk factor for CVD. Waist circumference (WC) cut-off point is a simple way ...
High blood pressure, overweight and obesity among rural scholars from the Vela Project: a population-based study from South America [0.03%]
VELA项目南美农村学者高血压、超重和肥胖的患病率及危险因素：一项基于人口的研究
Matías Tringler,Edgardo M Rodriguez,Darío Aguera et al.
Matías Tringler et al.
Background: Many studies have shown that high blood pressure and overweight begins in childhood. Consequently, it is useful to know blood pressure and body mass index (BMI) values from an early age. There are few data abo...
Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women [0.03%]
肥胖女性左心室肥厚的患病率及其左心室质量的影响因素
Guido Salvetti,Andrea Pucci,Paola Fierabracci et al.
Guido Salvetti et al.
Background: Obesity is frequently associated with left ventricular hypertrophy (LVH), a condition leading to an increased cardiovascular risk. Aim: ...
The role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical review [0.03%]
厄贝沙坦在高血压患者治疗中的作用：全面实用综述
Claudio Borghi,Arrigo F G Cicero
Claudio Borghi
Irbesartan is an orally active angiotensin II type 1 receptor antagonist (angiotensin receptor blocker [ARB]) whose pharmacological profile differs significantly from those of many other compounds of the same class. In particular, according...
Alberto Milan,Corrado Magnino,Ambra Fabbri et al.
Alberto Milan et al.
Primary aldosteronism is the most frequent cause of secondary hypertension, accounting for up to 11% of cases in selected populations. Patients affected by primary aldosteronism have shown higher prevalence of cardiovascular and cerebrovasc...
Ralph Knöll
Ralph Knöll
Cardiovascular diseases kill more people each year than any other diseases. In 2008, 7.3 million people died of ischaemic heart disease, 6.2 million from stroke or another form of cerebrovascular disease. Hypertension affects about 1 billio...
Obesity and hypertension in cardiac hypertrophy: two sides of the same coin? [0.03%]
肥胖和高血压在心脏肥厚中的作用：一枚硬币的两面？
Riccardo Sarzani,Federico Guerra
Riccardo Sarzani
Massimo Volpe
Massimo Volpe
Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome [0.03%]
肥胖高血压患者的微量白蛋白尿与左心室质量的关系及代谢综合征的作用
Federico Guerra,Lucia Mancinelli,Alessia Buglioni et al.
Federico Guerra et al.
Background: Left ventricular hypertrophy (LVH) and microalbuminuria are common in hypertensive patients and are often associated with metabolic syndrome (MetS). However, it is not clear whether MetS could modify the assoc...